Crossmark

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism

Crossref DOI link: https://doi.org/10.1136/bmjdrc-2019-000871

Published Online: 2020-03-17

Published Print: 2020-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Green, Charlotte J

Pramfalk, Camilla

Charlton, Catriona A

Gunn, Pippa J

Cornfield, Thomas

Pavlides, Michael

Karpe, Fredrik https://orcid.org/0000-0002-2751-1770
Hodson, Leanne https://orcid.org/0000-0002-2648-6526
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01936779 at ClinicalTrials.gov

Documents that mention this clinical trial

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism ^(Results)
https://doi.org/10.1136/bmjdrc-2019-000871
Funding

Funding for this research was provided by:

British Heart Foundation (FS/11/18/28633)

British Heart Foundation (FS/15/56/31645)
License Information

License valid from 2020-03-17